Welcome to Chemistry and Industry of Forest Products,

›› 2013, Vol. 33 ›› Issue (2): 71-76.doi: 10.3969/j.issn.0253-2417.2013.02.012

• 研究报告 • Previous Articles     Next Articles

Molecular Structure of Lignin Pharmaceutical Samples by Reductive Cleavage

ZHANG Jing1, XU Ge1, YU Da-gang2, WU Guo-ping2, CHEN He-xin2   

  1. 1. School of Petrochemical Engineering, Changzhou University, Changzhou 213164, China;2. Jiangsu Jianmin Pharmaceutical Co. Ltd., Changzhou 213018, China
  • Received:2012-03-26 Revised:1900-01-01 Online:2013-04-30 Published:2013-04-30

Abstract: Degradation of lignin pharmaceutical by derivatization followed by reductive cleavage (DFRC) was studied. The compositions and structures of degraded products were analyzed by GC-MS. The results showed that the degraded products from lignin pharmaceutical consisted of four types of compound, i.e., butylated hydroxyltoluene (BHT), monose, organic acid and related lignin units. In 1# and 2# pharmaceutical, the content of previous four kinds compounds was 12.696 %, 17.456 %, 17.989 % and 51.859 %; 8.736 %, 2.991 %, 44.812 % and 43.461 %, respectively. According to the biological activity of degraded products obtained by lignin pharmaceutical, the drug actions presumed could be due to the decomposition of lignin pharmaceutical in the human to BHT, ferulic acid and glycerine units. In 1# and 2# pharmaceutical, the content of total compounds converted into ferulic acid in the body was 12.572 % and 5.613 %. Furthermore, the content of total containing glycerine units compounds was 6.322 % and 25.430 %, respectively.

Key words: derivatization followed by reductive cleavage, lignin, pharmaceutical, GC-MS

CLC Number: